Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking

a technology of oxygen carrier and composition, which is applied in the field of preparation of heat stable oxygen carrier-containing pharmaceutical composition, can solve the problems of affecting the sustainability of functional hemoglobin in circulation, affecting the stability of plasma hemoglobin, and substantial renal injury

a technology of oxygen carrier and composition, which is applied in the field of preparation of heat stable oxygen carrier-containing pharmaceutical composition, can solve the problems of affecting the sustainability of functional hemoglobin in circulation, affecting the stability of plasma hemoglobin, and substantial renal injury

US20130052232A1Inactive Publication Date: 2013-02-28BILLION KING INT

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
  • Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
  • Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0061]Process Overview

[0062]A schematic flow diagram of the process of the present invention is illustrated in FIG. 1. Bovine whole blood is collected into an enclosed sterile container / bag containing 3.8% (w / v) tri-sodium citrate solution as anti-coagulant. Blood is then immediately mixed well with tri-sodium citrate solution to inhibit blood clotting. Red blood cells (RBC) are isolated and collected from plasma and other smaller blood cells by an apheresis mechanism. A “cell washer” is used for this procedure with gamma sterilized disposable centrifuge bowl. RBC are washed with an equal volume of 0.9% (w / v sodium chloride) saline.

[0063]Washed RBC are lysed to release hemoglobin content by manipulating hypotonic shock to the RBC cell membrane. A specialized instant cytolysis apparatus for RBC lysis device depicted in FIG. 2 is used for this purpose. Following RBC lysis, hemoglobin molecules are isolated from other proteins by tangential-flow ultrafiltration using a 100 kDa membrane...

example 2

[0065]Time & Controlled Hypotonic Lysis and Filtration

[0066]Bovine whole blood is freshly collected and transported under a cool condition (2 to 10° C.). The red blood cells are separated from the plasma via a cell washer and subsequently with a 0.65 μm filtration. After washing the red blood cells (RBC) filtrate with 0.9% saline, the filtrate is disrupted by hypotonic lysis. The hypotonic lysis is performed by using the instant cytolysis apparatus depicted in FIG. 2. The instant cytolysis apparatus includes a static mixer to assist in cell lysis. A RBC suspension with controlled hemoglobin concentration (12-14 g / dL) is mixed with 4 volumes of purified water to generate a hypotonic shock to RBC cell membranes. The period of hypotonic shock is controlled to avoid unwanted lysis of white blood cells and platelets. The hypotonic solution passes through the static mixer portion of the instant cytolysis apparatus for 2 to 30 seconds or otherwise a time sufficient to lyse the red blood ce...

example 3

[0068]Viral Clearance Study on Stroma-Free Hemoglobin Solution

[0069]In order to demonstrate the safety of the product from this invention, the virus removal abilities of (1) 0.65 μm diafiltration step and (2) 100 kDa ultrafiltration step are demonstrated by virus validation study. This is done by the deliberate spiking of a down-scaled version of these two processes with different model viruses (encephalomyocarditis virus, pseudorabies virus, bovine viral diarrhea virus and bovine parvovirus). In this study, four types of viruses (see Table 3) are used. These viruses vary in their biophysical and structural features and they display a variation in resistance to physical and chemical agents or treatments.

TABLE 3TargetSizeVirusModel VirusTaxonomyGenomeStructure[nm]Stability*HepatitisBovine viral diarrheaFlaviviridaessRNAenveloped40-60lowC virusvirus (BVDV)—EncephalomyocarditisPicornavirusssRNAnon-25-30mediumvirus (EMCV)envelopedParvovirusBovine parvovirusParvoviridaessDNAnon-18-26very...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
molecular weightaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

Methods for preparation of a heat stable hemoglobin based oxygen-carrier-containing pharmaceutical composition such that beta-beta cross-linking is favored are provided. Using the methods of the present invention, the oxygen affinity of the resultant molecule can be controlled so that hemoglobin based oxygen carriers tailored for specific applications can be produced. Lower oxygen affinity crosslinked hemoglobin is useful for applications requiring rapid tissue oxygenation (e.g. hemorrhagic shock) while higher oxygen affinity cross-linked hemoglobin is useful for applications requiring a slower rate of oxygenation (e.g. cancer adjunct therapy). A highly purified and heat stable crosslinked non-polymeric tetrameric hemoglobin having beta-beta cross-linking of greater than 40-60% and suitable for use in mammals without causing renal injury and vasoconstriction is produced. A high temperature and short time (HTST) heat processing step is performed to effectively remove any undesired dimeric hemoglobin, non-crosslinked tetrameric hemoglobin, and plasma protein impurities.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application claims priority to provisional U.S. Patent Application No. 61 / 529,279 filed Aug. 31, 2011, the disclosure of which is incorporated by reference herein.COPYRIGHT NOTICE / PERMISSION[0002]A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever. The following notice applies to the processes, experiments, and data as described below and in the drawings attached hereto: Copyright © 2011, Billion King International Limited, All Rights Reserved.TECHNICAL FIELD[0003]The present invention relates to methods for the preparation of a heat stable oxygen-carrier-containing pharmaceutical composition such that beta-beta cross-l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
28 Feb 2013
Publication
US20130052232A1
IPC
A61K9/00; C12N5/071; A61P9/00; A61K38/42
CPC
A61K38/42; A61P17/00; A61P43/00; A61P7/00; A61P7/08; A61P9/00; A61K47/50; A61K9/08
Inventors
WONG, BING LOU; KWOK, SUI YI